Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 1
Results: 13
Editorial Board: Arch Pharm (1/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202270002
- Publication type:
- Article
Cover Picture: Arch Pharm (1/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202270001
- Publication type:
- Article
Archiv der Pharmazie—200 years.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100392
- By:
- Publication type:
- Article
Design and development of novel series of indole‐3‐sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100333
- By:
- Publication type:
- Article
Antiproliferative, proapoptotic, and tumor‐suppressing effects of the novel anticancer agent alsevirone in prostate cancer cells and xenografts.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100316
- By:
- Publication type:
- Article
Green synthesis of novel antifungal 1,2,4‐triazoles effective against γ‐irradiated Candida parapsilosis.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100287
- By:
- Publication type:
- Article
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR‐2 inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100278
- By:
- Publication type:
- Article
The anticancer activity of carbazole alkaloids.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100277
- By:
- Publication type:
- Article
Design, synthesis, molecular modeling, and antimicrobial potential of novel 3‐[(1H‐pyrazol‐3‐yl)imino]indolin‐2‐one derivatives as DNA gyrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100266
- By:
- Publication type:
- Article
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100242
- By:
- Publication type:
- Article
Novel benzenesulfonamide‐bearing pyrazoles and 1,2,4‐thiadiazoles as selective carbonic anhydrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100241
- By:
- Publication type:
- Article
Design, synthesis, and evaluation of novel (E)‐N'‐(3‐allyl‐2‐hydroxy)benzylidene‐2‐(4‐oxoquinazolin‐3(4H)‐yl)acetohydrazides as antitumor agents.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100216
- By:
- Publication type:
- Article
1,2,3‐Triazole hybrids as anticancer agents: A review.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 1, p. 1, doi. 10.1002/ardp.202100158
- Publication type:
- Article